10x Genomics, Inc. TXG Americas — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s americas — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s americas — revenue?
- 10x Genomics, Inc. (TXG) reported americas — revenue of $80.1M in Q1 2026.
- How has 10x Genomics, Inc.'s americas — revenue changed year-over-year?
- 10x Genomics, Inc.'s americas — revenue decreased by 11.6% year-over-year, from $90.57M to $80.1M.
- What is the long-term trend for 10x Genomics, Inc.'s americas — revenue?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s americas — revenue has grown at a 7.9% compound annual growth rate (CAGR), from $264.99M to $358.77M.
- What does americas — revenue mean?
- This metric represents the total net sales generated from customers located within the Americas geographic region. It reflects the company's market penetration and demand for its life science instruments, consumables, and software solutions in this specific territory. Monitoring this figure helps investors assess regional growth trends and the effectiveness of local sales and distribution strategies.